Chang Yingjun
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CD19-BCMA Dual Nanobody Based CAR-T Cells for Patients With DSA (NCT07451236) | Chang Yingjun | 2026-03-18 |
Track Chang Yingjun automatically
Every clearance here is in the API, with alerts when new ones post.